Passing HB23-1110 Means Better Care, Healthier Outcomes and Millions in Savings for Patients HB23-1110 – The “Biomarker Bill” – awaits next action after overwhelmingly passing in the House Health & Insurance Committee Stakeholders across the state, including the American Cancer Society (“ACS”), have mobilized on this critical piece of legislation. ...
Read More